Channel Therapeutics Announces 10-for-1 Reverse Split, $50 Mln Placement
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 27 2025
0mins
Source: NASDAQ.COM
Reverse Stock Split Announcement: Channel Therapeutics Corp. will execute a 10-for-1 reverse stock split effective July 1, 2025, in conjunction with its merger with Pelthos Therapeutics and a $50.1 million private placement to enhance compliance with NYSE American listing requirements.
Company Focus and Stock Performance: The company is developing non-opioid pain treatments targeting the sodium ion channel NaV1.7, and its stock recently traded at $1.34, reflecting a 14.5% increase on the New York Stock Exchange.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
